Neurology

In this article, Ana Suller-Marti, Associate Professor of Neurology, Western University, London, Canada; James Wheless, Professor and…

Inside this issue, you will find a variety of content, including our independent review of the 11th Congress of the EAN, alongside exclusive..

Interview article with Prof. Abdelmoity, discussing the current treatment landscape for patients with drug-resistant epilepsy (DRE)…

CAR T Therapy: The NEX-T Frontier in MS, a BMS non-promotional symposium at ECTRIMS 2024, presents a thought-provoking view on the potential role of CAR-T cell therapy in Multiple Sclerosis. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. (IMM-GB-2400302) | Date of Prep: June 2025

This interview with a top thought leader from McGill University in Canada educates clinicians on important innovations in the field…

Learn about Becker Muscular Dystrophy (Becker), a serious, rare, and debilitating neuromuscular disease…

This article describes a recently initiated Phase II trial of a novel anti-tau monoclonal antibody, BMS-986446, the design for which was…

A satellite symposium titled ‘Transforming MS Care: Early Intervention and Sustained Safety’ held at the 40th Congress of the European…